The New England Journal of Medicine | Research & Review …
WEBThe New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
New England Journal of Medicine
WEBNEJM is a leading medical journal with high-quality research, reviews, and commentary. Access online articles, apps, subscriptions, and more.
Current Issue | New England Journal of Medicine
WEBExplore the current issue of The New England Journal of Medicine (Vol. 391 No. 13).
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients …
WEBApr 3, 2024 — Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk ...
Perioperative Durvalumab for Resectable Non–Small-Cell Lung …
WEBOct 23, 2023 — Lung cancer is the leading cause of cancer-related death worldwide, with non–small-cell lung cancer (NSCLC) accounting for over 80% of cases. 1-3 Approximately 25 to 30% of patients with NSCLC ...
Covid-19 Vaccines — Immunity, Variants, Boosters
WEBAug 31, 2022 — The coronavirus disease 2019 (Covid-19) pandemic has claimed an estimated 15 million lives, including more than 1 million lives in the United States alone. The rapid development of multiple Covid ...
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) …
WEBMar 2, 2022 — A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused ...
Coronavirus (Covid-19) | NEJM - The New England Journal of Medicine
WEBJul 17, 2024 — Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 — Discussion. A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with ...
Effectiveness of Bivalent Boosters against Severe Omicron Infection
WEBJan 25, 2023 — The results are shown in Table 1 and Figures S2 and S3. Booster effectiveness peaked at approximately 4 weeks and waned afterward. For all participants 12 years of age or older, vaccine ...